AMYLIN PHARMACEUTICALS INC: cashflow_investing

Value{"amount": 159669000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2010-01-01 – 2010-12-31
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001047469-11-001418 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:00.440667+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/cashflow-investing/2010-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/92dbaceb-bfd1-42ea-bd20-04ecff216090

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies